SMARCA2 and breast cancer: The increased PKM2 level was observed in BC cell resistant to cisplatin.33 Additionally, the TCGA BLCA database analysis indicated the SMARCA2 correlation with expression of genes involved in chromatin organization, transcription and various metabolic processes including nucleic acid metabolic processes, RNA metabolism, cellular metabolic processes, etc. (Supplementary Dataset 1).